Celiac Disease (CD)-Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Nov-2017
No. of pages: 67
Price : Single User: US $ 4950  US $ 3960 Corporate User: US $ 14850  US $ 8910
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023" report provides an overview of the disease and global market size of the Celiac Disease for the 6MM (United States and EU5 countries (France, Germany, Italy, Spain and UK)). It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Celiac Disease from 2013-2023.

Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The number of ways celiac disease can affect patients, combined with a lack of training in medical schools and primary care residency programs, contributes to the poor diagnosis rate. Currently it is estimated that 80% of the celiac disease population remains undiagnosed. Prevalence in Western Europe and in the United States ranges between 1 in 250 and 1 in 133. It is higher in relatives of people with celiac disease. Women are affected more commonly than men, but there is no age predilection. DelveInsight forecasts predict that the total prevalent cases of Celiac Disease is expected to accentuate up to 4.69 Million by 2023 at a Compound Annual Growth Rate (CAGR) of 0.46% from 2013-2023 while the diagnosed prevalent population of Celiac Disease in the 6MM shall grow at a CAGR of 0.15% for the forecast period (2013-2023).

There is no targeted therapy approved for celiac disease. The current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to reduce symptoms in severe cases. Owing to the expected launch of Larazotide Acetate (Innovate Pharmaceuticals) in 2021 followed by the launch of Latiglutenase (ImmunogenX/Abbvie) in 2023, shall lead to a hike in the otherwise stable, worldwide market size of celiac disease. DelveInsight estimates suggest that the global market size is expected to grow at a CAGR of 19% from 2013-2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- It focuses on the detailed historical and forecasted number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for 6MM from 2013-2023.

- The Report also includes historical and forecasted Market size of Celiac Disease for 6MM from 2013 to 2023.

- It provides the information of available marketed therapies, including off-label biologics, patent and exclusivity details.

- The report also focuses on the details of pipeline drugs in the pivotal stage of development including their SWOT Analysis and expected launch date, which shall help to predict the impact of those drugs on the market size in the near future.

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Celiac Disease (CD)-Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Report Introduction
Celiac Disease Market Size Overview at a Glance
Worldwide Market Size of Celiac Disease in 2013
Worldwide Market Size of Celiac Disease in 2023
Celiac Disease Overview
Celiac Disease Types
Non-Responsive or Refractory CD
Etiology
Symptoms
Diagnosis
Disease Management
Disease Treatment
Treatment of Celiac Disease
Treatment of Non-Responsive or Refractory Celiac Disease (RCD)
Current Unmet Medical Needs
Epidemiology Parameters
Iceberg Model
Genetic Predisposition
Epidemiology &Patient Population
United States
Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
EU5 Countries
France
Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Germany
Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Italy
Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Spain
Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
United Kingdom
Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Emerging Phase III Therapies
Larazotide acetate
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
Latiglutenase
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
AMG 714
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
Celiac Disease Market Size
Global Market Size of Celiac Disease (2013-2023)
Region-Wise Market size of Celiac Disease (2013-2023)
United States
Total Market Size of Celiac Disease (2013-2023)
European Five Countries
Italy
Total Market Size of Celiac Disease (2013-2023)
Germany
Total Market Size of Celiac Disease (2013-2023)
France
Total Market Size of Celiac Disease(2013-2023)
United Kingdom
Total Market Size of Celiac Disease (2013-2023)
Spain
Total Market Size of Celiac Disease (2013-2023)
Japan- Epidemiology and Market Size
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1:Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
Table 2:Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Table 3:Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Table 4:Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Table 5:Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Table 6:Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Table 7: Larazotide acetate, Clinical Trials by Zone, 2017
Table 8: Latiglutenase, Clinical Trials by Zone, 2017
Table 9: AMG 714, Clinical Trials by Zone, 2017
Table 11: Total Market size of Celiac Diseasein USD, Million(2013-2023)
Table 12: Total Market size of Celiac Disease (Region-Wise) in USD, Million(2013-2023)
Table 13: US market size of Celiac Diseasein USD, Million(2013-2023)
Table 14: Italy market size of Celiac Diseasein USD, Million(2013-2023)
Table 15: Germany market size of Celiac Disease in USD, Million(2013-2023)
Table 16: France market size of Celiac Diseasein USD, Million(2013-2023)
Table 17: United Kingdom market size of Celiac Diseasein USD, Million(2013-2023)
Table 18:Spain market size of Celiac Disease in USD, Million(2013-2023)

List of Figures

Figure 1: Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
Figure 2: Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Figure 3: Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Figure 4: Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Figure 5: Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Figure 6: Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Figure 7: Larazotide acetate, Clinical Trials by Zone (%), 2017
Figure 8: Latiglutenase, Clinical Trials by Zone (%), 2017
Figure 9: AMG 714, Clinical Trials by Zone (%), 2017
Figure 11: Total Market Size of Celiac Disease in USD, Million(2013-2023)
Figure 11: Region-Wise Market size of Celiac Disease in USD, Million(2013-2023)
Figure 13: US Market Size of Celiac Disease in USD, Million(2013-2023)
Figure 14: Italy market size of Celiac Disease in USD, Million(2013-2023)
Figure 15: Germany market size of Celiac Disease in USD, Million (2013-2023)
Figure 16: France market size of Celiac Disease in USD, Million(2013-2023)
Figure 17: United Kingdom market size of Celiac Disease in USD, Million(2013-2023)
Figure 18: Spain market size of Celiac Disease in USD, Million(2013-2023)
  • Global Gastrointestinal OTC Drugs Market Research Report 2017
    Published: 13-Nov-2017        Price: US 2900 Onwards        Pages: 114
    In this report, the global Gastrointestinal OTC Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal OTC Drugs in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Gastritis - Pipeline Review, H2 2017
    Published: 07-Nov-2017        Price: US 2000 Onwards        Pages: 51
    Gastritis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Pipeline Review, H2 2017, provides an overview of the Gastritis (Gastrointestinal) pipeline landscape. Gastritis is characterized by inflammation or swelling of the lining of the stomach. Acute gastritis lasts for a short period of time while chronic gastritis lasts for a long period of time (months to years). Gast......
  • Irritable Bowel Syndrome - Pipeline Review, H2 2017
    Published: 07-Nov-2017        Price: US 2000 Onwards        Pages: 154
    Irritable Bowel Syndrome - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2017, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape. Inflammatory Bowel Diseases (IBD) is a broad term that describes conditions with chronic or recurring immune response and inflammation of the gastrointestinal tract. Si......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Gastrointestinal Drug Market 2017 Forecast to 2022
    Published: 06-Nov-2017        Price: US 4880 Onwards        Pages: 121
    Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders. Scope of the Report: This report focuses on the Gastrointestinal Drug in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes......
  • Short Bowel Syndrome - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Short Bowel Syndrome - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Short Bowel Syndrome for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Short Bowel Syndrome . It enables understand......
  • Irritable Bowel Syndrome (IBS) - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Irritable Bowel Syndrome (IBS) - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Irritable Bowel Syndrome (IBS) - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients af......
  • Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Gastric Ulcers. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Gastric Ulcers which can turn out t......
  • Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 1500 Onwards        Pages: 40
    DelveInsight's, Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Helicobacter Pylori Infections. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Hel......
  • Traveler's Diarrhea - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Traveler's Diarrhea - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Traveler's Diarrhea for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Traveler's Diarrhea . It enables understanding......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs